Delivery Order SPE2DR25D3103-SPE2DR26F9L15
- Not listed
- The Defense Logistics Agency awarded a $14,592.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). This non-set-aside contract, which must be completed by December 23, 2025, represents a routine pharmaceutical procurement executed through the company's existing relationship with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). The contract is a firm fixed price delivery order with an ultimate completion date of December 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, valued at $14,592.57 for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This $14,592.57 firm fixed price delivery order has a completion date of December 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen...
- The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 31, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on August 22, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This competitive award, issued on November 20, 2025, with a completion date of December 12, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $14,592.57 on December 2, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract is non-competitive and carries a firm fixed price structure with an ultimate completion date of December 23, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This order, valued at $13,846.97 with a firm fixed price structure, represents a non-competitive, non-set-aside procurement issued under a delivery order contract type and is scheduled for completion by August 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this order was open to competition and reflects the agency's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L15Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on December 2, 2025, with completion targeted for December 23, 2025. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and fulfill the pharmaceutical supply requirement as part of its established relationship with the federal medical procurement system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 12/1/25 |